Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1086305 | Le Pharmacien Hospitalier et Clinicien | 2014 | 10 Pages |
Abstract
For separate indications, no study assessing this combination interest among the elderly is currently available. Nevertheless, an individual and objective risk-benefit ratio assessment (based on specific tools) would optimize the therapeutic management of these patients.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
S. Omrani, A. Brutel, R. Faure, L. Bourguignon, Y. Guilhermet, C. Mouchoux,